132 related articles for article (PubMed ID: 30724601)
1. [Utilization indicators of balneotherapy in Hungary].
Varga V; Boncz I; Sebestyén A; Endrei D; Ágoston I; Péter I; Molics B
Orv Hetil; 2019 Feb; 160(Suppl 1):22-28. PubMed ID: 30724601
[TBL] [Abstract][Full Text] [Related]
2. [Health insurance pharmaceutical expenditures in Hungary].
Eisingerné Balassa B; Csákvári T; Ágoston I
Orv Hetil; 2019 Feb; 160(Suppl 1):49-54. PubMed ID: 30724598
[TBL] [Abstract][Full Text] [Related]
3. [Epidemiological disease burden and annual health insurance treatment cost of colorectal cancer in Hungary].
Kívés Z; Endrei D; Elmer D; Csákvári T; Kajos LF; Boncz I; Mangel L; Mihály-Vajda R
Orv Hetil; 2021 Mar; 162(162 Suppl 1):14-21. PubMed ID: 33774604
[TBL] [Abstract][Full Text] [Related]
4. [Annual epidemiological and health insurance disease burden of pertrochanteric fractures in Hungary].
Gazsó T; Elmer D; Endrei D; Sebestyén A; Kajos LF; Wiegand N; Boncz I
Orv Hetil; 2021 Mar; 162(162 Suppl 1):46-53. PubMed ID: 33774608
[TBL] [Abstract][Full Text] [Related]
5. [Annual epidemiological and health insurance burden of cervical cancer in Hungary].
Mihály-Vajda R; Boncz I; Elmer D; Csákvári T; Németh N; Kajos LF; Pónusz-Kovács D; Bódis J; Kívés Z
Orv Hetil; 2021 Mar; 162(162 Suppl 1):22-29. PubMed ID: 33774605
[TBL] [Abstract][Full Text] [Related]
6. [Nationwide epidemiological and health insurance disease burden of rheumatoid arthritis in Hungary].
Elmer D; Endrei D; Sebestyén A; Csákvári T; Németh N; Horváth L; Pónusz R; Kumánovics G; Boncz I; Ágoston I
Orv Hetil; 2021 Mar; 162(162 Suppl 1):30-37. PubMed ID: 33774606
[TBL] [Abstract][Full Text] [Related]
7. [The nationwide epidemiological and health insurance disease burden of knee and lower leg injuries in Hungary].
Varga V; Elmer D; Boncz I; Sipos D; Kajos LF; Sebestyén A; Molics B
Orv Hetil; 2021 Mar; 162(162 Suppl 1):54-60. PubMed ID: 33774609
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of health insurance data on home nursing care in Hungary].
Cs Horváth Z; Sebestyén A; Molics B; Ágoston I; Endrei D; Oláh A; Betlehem J; Imre L; Bagosi G; Boncz I
Orv Hetil; 2014 Apr; 155(15):597-603. PubMed ID: 24704772
[TBL] [Abstract][Full Text] [Related]
9. [Health care costs of acute myocardial infarction in Hungary, 2003-2005].
Gulácsi L; Májer I; Boncz I; Brodszky V; Merkely B; Maurovich HP; Kárpáti K
Orv Hetil; 2007 Jul; 148(27):1259-66. PubMed ID: 17604262
[TBL] [Abstract][Full Text] [Related]
10. [Health policy indicators of neuromusculosceletal rehabilitation in Hungary].
Boncz I; Endrei D; Csákvári T; Ágoston I; Cserháti P; Molics B; Sebestyén A
Orv Hetil; 2019 Feb; 160(Suppl 1):13-21. PubMed ID: 30724604
[TBL] [Abstract][Full Text] [Related]
11. [Assessing the epidemiological disease burden and health insurance treatment cost of diabetic polyneuropathy based on health insurance claims data].
Csákvári T; Elmer D; Németh N; Kívés Z; Wittmann I; Janszky J; Boncz I
Orv Hetil; 2021 Mar; 162(162 Suppl 1):38-45. PubMed ID: 33774607
[TBL] [Abstract][Full Text] [Related]
12. [Performance indicators of cardiac rehabilitation in Hungary].
Boncz I; Sebestyén A; Csákvári T; Ágoston I; Szabados E; Endrei D
Orv Hetil; 2019 Feb; 160(Suppl 1):6-12. PubMed ID: 30724603
[TBL] [Abstract][Full Text] [Related]
13. The long-term effect of generic price competition on the Hungarian statin market.
Répásy B; Gazsó T; Elmer D; Pónusz-Kovács D; Kajos FL; Csákvári T; Kovács B; Boncz I
BMC Health Serv Res; 2023 May; 23(1):447. PubMed ID: 37147682
[TBL] [Abstract][Full Text] [Related]
14. [Physiotherapy from the view of health insurance financing].
Géher P
Orv Hetil; 2013 Dec; 154(48):1917-23. PubMed ID: 24273291
[TBL] [Abstract][Full Text] [Related]
15. [Epidemiological disease burden and annual health insurance treatment cost of acute myocardial infarction in Hungary].
Németh N; Endrei D; Elmer D; Csákvári T; Horváth L; Kajos LF; Cziráki A; Boncz I
Orv Hetil; 2021 Mar; 162(162 Suppl 1):6-13. PubMed ID: 33774610
[TBL] [Abstract][Full Text] [Related]
16. [Changes in disability, reduced working ability and rehabilitation benefits in Hungary between 1990 and 2015].
Kovács G
Orv Hetil; 2019 Feb; 160(Suppl 1):29-36. PubMed ID: 30724599
[TBL] [Abstract][Full Text] [Related]
17. [Assessment of annual health insurance reimbursement for oncology drugs in Hungary].
Boncz I; Donkáné Verebes E; Oberfrank F; Kásler M
Magy Onkol; 2010 Dec; 54(4):283-8. PubMed ID: 21163758
[TBL] [Abstract][Full Text] [Related]
18. Price competition and reimbursement of biosimilar granulocyte-colony stimulating factor in Hungary.
Hornyák L; Nagy Z; Ilku L; Tálos Z; Endrei D; Ágoston I; Csákvári T; Danku N; Répásy B; Boncz I
Expert Rev Pharmacoecon Outcomes Res; 2019 Dec; 19(6):725-731. PubMed ID: 30763134
[No Abstract] [Full Text] [Related]
19. [Social insurance costs of hospital treatment of stroke in Hungary, 2003-2005].
Kárpáti K; Májer I; Boncz I; Nagy A; Bereczki D; Gulácsi L
Ideggyogy Sz; 2007 Jul; 60(7-8):311-20. PubMed ID: 17713112
[TBL] [Abstract][Full Text] [Related]
20. [Health policy experiences of publicly financed laboratory services in Hungary with health insurance data analysis].
Boncz I; Sebestyén A; Endrei D; Ágoston I; Csákvári T; Kovács LG; Miseta A
Orv Hetil; 2020 Mar; 161(12):468-473. PubMed ID: 32172584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
